PL2117524T3 - Zastosowanie katecholamin i pokrewnych związków jako środków przeciwangiogennych - Google Patents
Zastosowanie katecholamin i pokrewnych związków jako środków przeciwangiogennychInfo
- Publication number
- PL2117524T3 PL2117524T3 PL08706338T PL08706338T PL2117524T3 PL 2117524 T3 PL2117524 T3 PL 2117524T3 PL 08706338 T PL08706338 T PL 08706338T PL 08706338 T PL08706338 T PL 08706338T PL 2117524 T3 PL2117524 T3 PL 2117524T3
- Authority
- PL
- Poland
- Prior art keywords
- catecholamines
- related compounds
- angiogenic agents
- angiogenic
- agents
- Prior art date
Links
- 239000004037 angiogenesis inhibitor Substances 0.000 title 1
- 150000003943 catecholamines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89781407P | 2007-01-29 | 2007-01-29 | |
| US92467407P | 2007-05-25 | 2007-05-25 | |
| PCT/CA2008/000191 WO2008092257A1 (en) | 2007-01-29 | 2008-01-29 | Use of catecholamines and related compounds as anti-angiogenic agents |
| EP08706338.4A EP2117524B8 (en) | 2007-01-29 | 2008-01-29 | Use of catecholamines and related compounds as anti-angiogenic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2117524T3 true PL2117524T3 (pl) | 2020-03-31 |
Family
ID=39673602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08706338T PL2117524T3 (pl) | 2007-01-29 | 2008-01-29 | Zastosowanie katecholamin i pokrewnych związków jako środków przeciwangiogennych |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9351947B2 (pl) |
| EP (1) | EP2117524B8 (pl) |
| JP (1) | JP2010516716A (pl) |
| AU (1) | AU2008210237B2 (pl) |
| CA (1) | CA2675148C (pl) |
| ES (1) | ES2753850T3 (pl) |
| PL (1) | PL2117524T3 (pl) |
| WO (1) | WO2008092257A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010516716A (ja) * | 2007-01-29 | 2010-05-20 | ナショナル・リサーチ・カウンシル・オブ・カナダ | 血管新生阻害剤としてのカテコールアミン及び関連化合物の使用 |
| EP2271341B1 (en) * | 2008-05-08 | 2016-08-17 | Nova Southeastern University | Specific inhibitors for vascular endothelial growth factor receptors |
| WO2010107866A2 (en) * | 2009-03-20 | 2010-09-23 | Emory University | Catecholamine derivatives for obesity and neurological disorders |
| CN112730699A (zh) * | 2020-12-18 | 2021-04-30 | 杭州汉库医学检验所有限公司 | 一种用于检测血浆中儿茶酚胺及代谢物的方法及试剂盒 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3885047A (en) * | 1972-06-16 | 1975-05-20 | Mead Johnson & Co | Ocular hypotensive process employing dextrorotatory phenethanolamines |
| US3985897A (en) * | 1973-12-21 | 1976-10-12 | Mead Johnson & Company | Ocular hypotensive process employing dextrorotatory sulfonamidophenethanolamines |
| US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
| US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
| MX9701282A (es) * | 1994-08-18 | 1997-05-31 | Pfizer | Fenoles neuroprotectores. |
| JPH09136830A (ja) * | 1995-11-15 | 1997-05-27 | Kagaku Gijutsu Shinko Jigyodan | 網膜保護剤 |
| EP1435930A2 (en) * | 2001-10-15 | 2004-07-14 | National Research Council Of Canada | Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| IL147921A0 (en) * | 2002-01-31 | 2002-08-14 | Abdulrazik Mohammad | A method for treating central nervous system disorders by ocular dosing |
| US7307079B2 (en) * | 2002-05-30 | 2007-12-11 | Solvay Pharmaceuticals, B.V. | 1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors |
| BR0314364A (pt) * | 2002-09-16 | 2005-07-19 | Alcon Mfg Ltd | Uso de inibidores de pde iv para tratar angiogênese |
| WO2006015830A1 (en) | 2004-08-09 | 2006-02-16 | Universite Catholique De Louvain | Use of agonists and antagonists of beta-adrenoceptors for treating arterial diseases |
| WO2007013997A2 (en) * | 2005-07-22 | 2007-02-01 | H. Lee Moffitt Cancer Center And Research Institute | Inhibition of the raf/mek/p-erk pathway for treating cancer |
| US20070112076A1 (en) * | 2005-11-16 | 2007-05-17 | Southern Illinois University | Methods and materials for treating retinopathy |
| WO2007109882A1 (en) * | 2006-03-24 | 2007-10-04 | National Research Council Of Canada | Anti-diabetic cataract compounds and their uses |
| JP2010516716A (ja) * | 2007-01-29 | 2010-05-20 | ナショナル・リサーチ・カウンシル・オブ・カナダ | 血管新生阻害剤としてのカテコールアミン及び関連化合物の使用 |
-
2008
- 2008-01-29 JP JP2009546629A patent/JP2010516716A/ja active Pending
- 2008-01-29 EP EP08706338.4A patent/EP2117524B8/en active Active
- 2008-01-29 ES ES08706338T patent/ES2753850T3/es active Active
- 2008-01-29 AU AU2008210237A patent/AU2008210237B2/en active Active
- 2008-01-29 WO PCT/CA2008/000191 patent/WO2008092257A1/en not_active Ceased
- 2008-01-29 US US12/448,981 patent/US9351947B2/en active Active
- 2008-01-29 PL PL08706338T patent/PL2117524T3/pl unknown
- 2008-01-29 CA CA2675148A patent/CA2675148C/en active Active
-
2016
- 2016-05-10 US US15/150,835 patent/US20170027888A1/en not_active Abandoned
- 2016-05-10 US US15/150,935 patent/US20170027889A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008210237A1 (en) | 2008-08-07 |
| EP2117524B8 (en) | 2019-09-25 |
| CA2675148C (en) | 2015-07-21 |
| US20170027889A1 (en) | 2017-02-02 |
| JP2010516716A (ja) | 2010-05-20 |
| AU2008210237B2 (en) | 2013-05-02 |
| WO2008092257A1 (en) | 2008-08-07 |
| US20100069401A1 (en) | 2010-03-18 |
| ES2753850T3 (es) | 2020-04-14 |
| EP2117524A4 (en) | 2012-07-04 |
| EP2117524B1 (en) | 2019-08-14 |
| EP2117524A1 (en) | 2009-11-18 |
| US9351947B2 (en) | 2016-05-31 |
| CA2675148A1 (en) | 2008-08-07 |
| US20170027888A1 (en) | 2017-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1900009I1 (hu) | Új vegyületek és készítmények, továbbá alkalmazási eljárásaik | |
| GB2469245B (en) | Antimicrobial compositions and methods of use thereof | |
| ZA201002317B (en) | Parp inhibitor compounds,compositions and methods of use | |
| ZA201008713B (en) | Antimicrobial compositions and methods of use | |
| ZA201104463B (en) | Compounds and methods of use | |
| PL2346327T3 (pl) | Kompozycje biobójcze i sposoby stosowania | |
| GB0818241D0 (en) | Compounds and their use | |
| SI2344449T1 (sl) | Aril-fenil-sulfonamido-cikloalkilne spojine in njihova uporaba | |
| EP2326171A4 (en) | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE | |
| IL208081A0 (en) | Amido - thiophene compounds and their use | |
| IL208403A0 (en) | Compositions and use of epas1 inhibitors | |
| HRP20160902T1 (hr) | Pripravci i postupci uporabe forbolskih estera | |
| ZA201007395B (en) | Aryl-quinolyl compounds and their use | |
| EP2117524B8 (en) | Use of catecholamines and related compounds as anti-angiogenic agents | |
| ZA201003156B (en) | Use of liquefied-gas compositions | |
| PL2237782T3 (pl) | Zastosowanie tetrahydropirymidyn | |
| TWI367210B (en) | Estrogenic-active compounds and application thereof | |
| GB0801319D0 (en) | Compounds and their use | |
| PT2117524T (pt) | Utilização de catecolaminas e compostos relacionados como agentes antiangiogénicos | |
| PL378852A1 (pl) | Zastosowanie karotolu jako środka przeciwgrzybowego | |
| HU0800656D0 (en) | Effective use of tea-composition | |
| HK1135282A (zh) | 抗血管形成劑和其使用方法 | |
| GB0805693D0 (en) | Combinations of P13-delta and P13-gamma kinase inhibitor compounds | |
| GB0802194D0 (en) | Compounds and their use | |
| GB0813254D0 (en) | Compounds and their use |